研究伙伴在纵向阿尔茨海默病研究中对报酬的看法
Erin D Solomon1, Matthew Gabel2, Semere Bekena1
1Bioethics Research Center, Washington University, St. Louis, Missouri, USA.
Alzheimer's & dementia. Behavior & socioeconomics of aging
|December 8, 2025
概括
在阿尔茨海默病研究中的研究伙伴通常接受经济补偿. 提供报酬可能会提高招聘和留住人数,特别是在临床试验中代表性不足的群体.
科学领域:
- 神经科学是一个神经科学.
- 临床研究 临床研究
背景情况:
- 为阿尔茨海默病 (AD) 研究招募和留住参与者面临着持续的挑战.
- 薪酬是一个可修改的因素,可以潜在地提高参与者参与纵向观察性AD研究的参与度.
研究的目的:
- 调查研究伙伴对阿尔茨海默病研究中报酬的看法.
- 评估报酬对招聘和留住员工的潜在影响.
主要方法:
- 在美国阿尔茨海默氏症疾病研究中心对517名研究伙伴进行了一项调查.
- 该调查重点关注参与者对收到报酬的看法和态度.
主要成果:
- 研究伙伴通常对报酬持中立至积极的观点.
- 自称黑人研究伙伴报告比白人研究伙伴更积极的观点.
- 受个人利益或感知较低负担的参与者对报酬的看法不那么有利,尽管利他主义仍然是一个强有力的激励因素.
结论:
- 大多数阿尔茨海默病研究合作伙伴认为报酬是可以接受的.
- 财政补偿可以作为一种有价值的工具,以改善多样化和代表性不足的人群在AD研究中的招聘和保留.
相关概念视频
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
Longitudinal Studies
449
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
449
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


